What researchers published on Diffuse large B-cell lymphoma
1,634 papers, newest first.
Showing 20 of 1,634
Case reportDiffuse Large B-Cell Lymphoma Presenting as Clinically Isolated Massive Splenic Disease: A Case Report.Cureus
Not labelled yetDynamic prognostic stratification and survival prediction in elderly patients with diffuse large B-cell lymphoma: a real-world evidence study.BMC cancer
Case reportIntermittent reduced-dose methotrexate enabled continuation of induction therapy despite severe delayed methotrexate elimination in primary central nervous system lymphoma: a case report.Journal of medical case reports
Review[Treatment strategies for lymphoma in older adults].[Rinsho ketsueki] The Japanese journal of clinical hematology
Not labelled yetPatient-reported Outcomes in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Treated With Glofitamab Plus Gemcitabine and Oxaliplatin in STARGLO.Clinical lymphoma, myeloma & leukemia
Not labelled yetTemporal clinical trajectories and Day+14 landmark stratification of infection risk after CD19 CAR T-cell therapy.Frontiers in cellular and infection microbiology
Not labelled yetDiffuse Large B-Cell Lymphoma Presenting as a Rapidly Enlarging Forehead Mass Initially Suggestive of a Subgaleal Hematoma: A Case Report.Clinical case reports
Case reportDiffuse Large B-cell Lymphoma With Tumor Thrombus in the Superior Mesenteric Vein: A Case Report.Cureus
Not labelled yetHypoxia-induced NETs establish a self-reinforcing immunosuppressive circuit that can be targeted to enhance immunotherapy in DLBCL.Journal of translational medicine
Not labelled yetCorrection: Deceptive initial presentation of systemic DLBCL with CNS progression following oligometabolic PET/CT: case report.Frontiers in oncology
Case reportPrimary Cervical Diffuse Large B-cell Lymphoma Incidentally Diagnosed During Evaluation of High-Grade Cervical Dysplasia: A Case Report.Cureus
Not labelled yetProjected population size by treatment line in diffuse large B-cell lymphoma in the United States, 2024-2028.Leukemia & lymphoma
Not labelled yetExpression profiles of long non-coding RNAs ROCR, CFLAR-AS1, ST7-AS1, and ST7-AS2 in diffuse large B-cell lymphoma: a case-control study focusing on GCB and non-GCB subtypes.BMC medical genomics
Not labelled yetCorrection: Zanubrutinib combined with R-CHOP in previously untreated diffuse large B-cell lymphoma with specific gene alteration: a phase II study.Blood cancer journal
Case report[Cardiac Malignant Lymphoma with Right Atrial Occlusion Responding to Tumor Resection and Postoperative Chemotherapy:Report of a Case].Kyobu geka. The Japanese journal of thoracic surgery
Not labelled yetEfficacy and safety of orelabrutinib plus R-CDOP as first-line therapy in diffuse large B-cell lymphoma with high-risk CNS-IPI: a prospective, multicenter, single-arm, phase II study.Frontiers in oncology
Case reportLower Back Pain As the Initial Manifestation of Primary Follicular B-cell Non-Hodgkin Lymphoma of the Bone Marrow: A Case Report.Cureus
Not labelled yetGeneration and multidimensional profiling of a rituximab-resistant ABC-type diffuse large B-cell lymphoma cell line.Epigenomics
Not labelled yetThe cyclin-G associated kinase (GAK) is a clinically actionable drug target required for mitosis in diffuse large B-cell lymphoma.Leukemia
ReviewProgression-free survival prediction in diffuse large B-cell lymphoma: where can we further improve?Expert review of hematology